Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
sRPmZ8jdTDHQHdHB